Literature DB >> 15061175

Uterine artery anatomy relevant to uterine leiomyomata embolization.

Jackeline Gomez-Jorge1, Andrew Keyoung, Elliot B Levy, James B Spies.   

Abstract

To categorize the anatomic variants of uterine arteries, and determine the incidence of menopausal symptoms where the tubo-ovarian branches were seen prior to embolization. Between July 1997 and June 2000, 257 (n = 257) uterine fibroid embolizations were performed at our institution. Arteriograms were retrospectively evaluated. Uterine arteries were classified into groups: type I (the uterine artery as first branch of the inferior gluteal artery), type II (the uterine artery as second or third branch of the inferior gluteal artery), type III (the uterine artery, the inferior gluteal and the superior gluteal arteries arising as a trifurcation), type IV (the uterine artery as first branch of the hypogastric artery), inconclusive, or not studied. Tubo-ovarian branches were recorded if visualized prior to and/or after embolization. Menopausal symptoms were recorded (n = 175 at 3 months, n = 139 at 6 months, n = 98 at 1 year, n = 22 at 2 years) using written questionnaires. Five hundred and fourteen uterine arteries (n = 514) were evaluated. There were 38% classifiable types, 23% inconclusive, and 39% not studied. Classification was as follows: type I, 45%; type II, 6%; type III, 43%; type IV, 6%. Among 256 patients, tubo-ovarian arteries were seen in 36 prior to embolization, but not afterwards. In this group, 25 patients reported transient menopausal symptoms (hot flashes, amenorrhea). Five patients did not report any menopausal symptoms. Six patients did not answer the questionnaires. Type I is the most common type of anatomy, followed by type III. The tubo-ovarian arteries may be visualized prior to and/or after embolization. The embolization was monitored to avoid embolization of the tubo-ovarian branches. Menopausal symptoms were transient all patients when the tubo-ovarian branches were seen prior to embolization.

Entities:  

Mesh:

Year:  2003        PMID: 15061175     DOI: 10.1007/s00270-003-2652-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  8 in total

1.  Three-dimensional computed tomography angiography reconstruction of the origin of the uterine artery and its clinical significance.

Authors:  Alexandra Arfi; Julia Arfi-Rouche; Vincent Barrau; Krystel Nyangoh Timoh; Cyril Touboul
Journal:  Surg Radiol Anat       Date:  2017-11-09       Impact factor: 1.246

Review 2.  Preprocedural MRI and MRA in planning fibroid embolization.

Authors:  Cristina Maciel; Yen Zhi Tang; Anju Sahdev; António Miguel Madureira; Paulo Vilares Morgado
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

3.  Uterine artery embolisation for uterine fibroids: Our experience at a tertiary care service hospital.

Authors:  John Dsouza; Sushil Kumar; P C Hande; S N Singh
Journal:  Med J Armed Forces India       Date:  2015-06-18

4.  Uterine artery occlusion for treatment of symptomatic uterine myomas.

Authors:  Adel Helal; Abd El-Mageed Mashaly; Talal Amer
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

5.  Uterine artery emerging variants - angiographic aspects.

Authors:  Dana Albulescu; C Constantin; Constantin Constantin
Journal:  Curr Health Sci J       Date:  2014-08-04

Review 6.  Anatomic variations of the Uterine Artery. Review of the literature and their clinical significance.

Authors:  Konstantinos Liapis; Nikolaos Tasis; Ioannis Tsouknidas; George Tsakotos; Panagiotis Skandalakis; Konstantinos Vlasis; Dimitrios Filippou
Journal:  Turk J Obstet Gynecol       Date:  2020-04-06

7.  The extremely rare vascular variant of a segmental duplicated uterine artery and its relevance for the interventionist and gynecologist: a case report.

Authors:  Gernot Rott; Frieder Boecker
Journal:  J Med Case Rep       Date:  2016-06-04

8.  Uterus transplant graft's arterial atherosclerotic remodeling veracity.

Authors:  Robert Novotny; Jaroslav Chlupac; Jakub Kristek; Jan Pit'ha; Roman Chmel; Eva Sticova; Libor Janousek; Jiri Fronek
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.